SCHEMBL7143754

SCHEMBL7143754

COc1ccc2cc(C3CCN(C(=O)OC(C)(C)C)C(C)C3)sc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.45
SLC6A4 P31645 1/20 0.45
KDM4E B2RXH2 4/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
DYRK1A Q13627 1/20 0.40
CHRNA7 P36544 3/20 0.39
HTT P42858 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 3/20 0.39
TSHR P16473 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
HSD17B10 Q99714 1/20 0.39
STS P08842 1/20 0.38
ROCK2 O75116 4/20 0.37
PRKG1 Q13976 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7099768 0.88 L3MBTL1 (0.46) HTR1ASLC6A4L3MBTL1CHRNA7KMT2A
SCHEMBL7151596 0.83 KDM4E (0.44) KDM4ENPC1RAB9AL3MBTL1HTT
SCHEMBL18618470 0.79 ALDH1A1 (0.48) KDM4EHTTMEN1KMT2AALDH1A1
SCHEMBL25168119 0.77 DPP4 (0.37) KDM4EL3MBTL1
SCHEMBL7146974 0.76 HTR1A (0.39) HTR1ASLC6A4
SCHEMBL5756452 0.75 CHRNA7 (0.39) KDM4ENPC1RAB9AL3MBTL1DYRK1A
SCHEMBL24164065 0.73 GPR119 (0.37) KDM4ENPC1RAB9AL3MBTL1ALDH1A1
SCHEMBL7099217 0.73 GPR119 (0.51) KDM4EL3MBTL1MEN1KMT2AEPHX2
Water SCHEMBL8023337 0.72 DYRK1A (0.41) HTR1AKDM4EDYRK1ACHRNA7HTT
SCHEMBL23868538 0.71 ROCK2 (0.50) ROCK2PRKG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030153764-A1 Process for preparing 4-substituted piperidines ELI LILLY AND COMPANY 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153764-A1 Process for preparing 4-substituted piperidines PDGFRA, GTF3C5, GRIA4 HTR1A 316/4885SLC6A4 1890/4885KDM4E 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.